Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06853535Phase 3Recruiting

Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE

Role: collaborator

NCT06575283Not Yet Recruiting

Predicting Cerebral Palsy in Infants With White Matter Injury Using MRI

Role: collaborator

NCT02215642Unknown

Nutrition and Lifestyle Study Cohort of Colorectal Cancer in China

Role: collaborator

NCT02216955Unknown

Nutrition and Lifestyle Study Cohort of Gastric Cancer in China

Role: collaborator

NCT01196260Phase 2Unknown

Combination Chemotherapy Treatments in Patients With Colorectal Cancer Stage II and III

Role: collaborator

All 5 trials loaded